Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)

H Andrew W Neil, David A DeMicco, Don Luo, D John Betteridge, Helen M Colhoun, Paul N Durrington, Shona J Livingstone, John H Fuller, Graham A Hitman, CARDS Study Investigators

    Research output: Contribution to journalArticle

    79 Citations (Scopus)

    Abstract

    Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 diabetes. We conducted a post hoc analysis to compare the efficacy and safety of atorvastatin among 1,129 patients aged 65-75 years at randomization with 1,709 younger patients in the Collaborative Atorvastatin Diabetes Study (CARDS).
    Original languageEnglish
    Pages (from-to)2378-2384
    Number of pages7
    JournalDiabetes Care
    Volume29
    Issue number11
    DOIs
    Publication statusPublished - 2006

    Fingerprint Dive into the research topics of 'Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS)'. Together they form a unique fingerprint.

  • Cite this

    Neil, H. A. W., DeMicco, D. A., Luo, D., Betteridge, D. J., Colhoun, H. M., Durrington, P. N., Livingstone, S. J., Fuller, J. H., Hitman, G. A., & CARDS Study Investigators (2006). Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care, 29(11), 2378-2384. https://doi.org/10.2337/dc06-0872